Top Section/Ad
Top Section/Ad
Most recent
Dasha Sobornova joins from Akin Gump with experience across asset classes
Trade body for levfin investors turns to leading rating analyst
Demand for riskiest tranches and improved loan supply could support growth in issuance
Dana Point 'no longer the end' of the year as market retains momentum
More articles/Ad
More articles/Ad
More articles
-
UK CLO managers who fund CLO risk retention through the sponsor route are scrambling to set up alternative structures in the wake of the British referendum result, which could see the end of passporting rules and threaten the ability of UK based managers to run European CLOs. -
Valeant Pharmaceuticals is facing an important test in its ability to reverse its fortunes this summer, as CLO market players say that the fate of the Canadian pharmaceutical giant will have a substantial effect on the sector.
-
Copenhagen-based Accunia is about to become the first Nordic asset manager to price a CLO, expecting to price a €360.5m deal this week.
-
This year has seen increased cross-Atlantic activity, as European investors hunt yield in the US market and US managers look to set up shop in Europe, eyeing up the tighter spreads available. This could mark the emergence of a truly global market, but will the increasing globalisation of the CLO sector help the European market flourish?
-
Two large CLO managers are looking at a potential merger or acquisition of rival CIFC, as the projected wave of manager consolidation gains steam in 2016.
-
Cairn landed a €362m CLO last Thursday, as debut issuer Accunia lines up its first deal.
